Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.5M Sell
51,004
-5,365
-10% -$1.84M 0.19% 121
2026
Q1
$19.8M Buy
56,369
+1,365
+2% +$487K 0.23% 98
2025
Q4
$18M Sell
55,004
-502
-0.9% -$159K 0.21% 94
2025
Q3
$15.7M Sell
55,506
-276
-0.5% -$80K 0.19% 106
2025
Q2
$15.6M Sell
55,782
-322
-0.6% -$91.2K 0.2% 101
2025
Q1
$17.5M Buy
+56,104
New +$16.6M 0.26% 86

Other funds holding AMGN

ASR Vermogensbeheer's AMGN Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Amgen (AMGN) stake by 9.5% in Q2 2026, selling an estimated $1.84M and leaving 51,004 shares worth $18.5M. The position accounts for 0.19% of the portfolio, ranked #121.

ASR Vermogensbeheer first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $19.8M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • ASR Vermogensbeheer held 51,004 shares of Amgen worth $18.5M as of Q2 2026.
  • ASR Vermogensbeheer sold 5,365 Amgen shares in Q2 2026, an estimated $1.84M.
  • Amgen made up 0.19% of ASR Vermogensbeheer's portfolio in Q2 2026, its #121 holding.
  • ASR Vermogensbeheer first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Amgen position peaked at $19.8M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.